Article(id=1327671202388227062, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671134016876766, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.12.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1646064000000, receivedDateStr=2022-03-01, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471081587, onlineDateStr=2026-11-12, pubDate=1670601600000, pubDateStr=2022-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471081587, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471081587, creator=13701087609, updateTime=1794471081587, updator=13701087609, issue=Issue{id=1327671134016876766, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='12', pageStart='1671', pageEnd='1823', issueExtLink='null', onlineDate='null', pubDate='1670601600000', pubDateStr='2022-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471065286, creator='13701087609', updateTime=1794472341615, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327676487970435149, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671134016876766, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327676487970435150, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671134016876766, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1689, endPage=1698, ext={EN=ArticleExt(id=1327671202568582135, articleId=1327671202388227062, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Advances in LC-MS/MS for Biological Quantitative Analysis of Protein Drugs, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Protein drugs include therapeutic proteins with enzymatic or regulatory activity, targeted protein such as antibody drugs, protein vaccines and protein diagnostics. Protein drugs have been one of the most focused areas in new drug development due to their strong specificity, slight adverse drug reaction and significant therapeutic effect. With the rapid development of protein drugs, higher requirements are put forward for their bioanalysis methods. To support the research of pharmacokinetics and toxicokinetics, more sensitive, accurate and high-throughput bioanalytical methods need to be established. In recent years, LC-MS/MS has emerged as a promising and versatile tool for quantitative analysis of protein drugs, owing to its rapid development. In this study, the application progress of LC-MS/MS to the quantitative analysis of protein drugs is summarized, and the specific experimental process of bottom-up analysis method in detail is introduced, which provides a reference for the study of LC-MS/MS in the determination of protein drugs.

, authors=Jiayi YU1, 2, Yimeng HAO1, 3, Jing MA1, 2, *, authorsList=Jiayi YU, Yimeng HAO, Jing MA, authorCompany=null, correspAuthors=Jing MA, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327671203076092920, articleId=1327671202388227062, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=LC-MS/MS技术在蛋白质药物生物定量分析中的应用进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

蛋白质药物包括治疗用蛋白质(酶和调节蛋白)、靶向蛋白质(抗体药物)、蛋白质疫苗及诊断用蛋白质等,因特异性强、不良反应小且疗效显著而成为新药研发的热点领域之一。随着蛋白质药物的快速发展,对其生物分析方法也提出了更高的要求。为支持此类药物在药代动力学和毒代动力学方面的研究,需建立更加灵敏、准确和高通量的生物分析方法。近年来,液相色谱-串联质谱(LC-MS/MS)技术发展迅速,已成为蛋白质药物定量分析的新方法。该研究介绍了LC-MS/MS技术在蛋白质药物定量分析方法中的应用进展,并详细介绍了自下而上分析方法的具体试验流程,为LC-MS/MS技术测定蛋白质药物的研究提供了参考。

, authors=宇家仪1, 2, 郝依萌1, 3, 马璟1, 2, *, authorsList=宇家仪, 郝依萌, 马璟, authorCompany=null, correspAuthors=马璟, authorNote=

宇家仪(1996—),女,硕士,从事抗体分析研究。

, correspAuthorsNote=
马璟(1963—),女,研究员,博士生导师,从事药物毒理学/药理学的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=psBH6QBUbkUp7MIfgnyqDQ==, magXml=b7xrDVbSnP18rJ0BwnQ/bw==, pdfUrl=null, pdf=TyFl91HiPGqWcBHzqx1ZhA==, pdfFileSize=1673272, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=58AUaeeQ0o83sxBpBn7LoA==, mapNumber=null, fund=null)}, authors=[Author(id=1327671308873216833, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671308961297220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671308873216833, language=EN, stringName=Jiayi YU, firstName=Jiayi, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671309036794693, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671308873216833, language=CN, stringName=宇家仪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海益诺思生物技术股份有限公司,上海 201203, bio={"content":"

宇家仪(1996—),女,硕士,从事抗体分析研究。

"}, bioImg=null, bioContent=

宇家仪(1996—),女,硕士,从事抗体分析研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671308659307319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=1., ext=[AuthorCompanyExt(id=1327671308663501624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671308671890233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1327671308738999098, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=2., ext=[AuthorCompanyExt(id=1327671308743193403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1327671308747387708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1327671309108097863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671309217149770, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309108097863, language=EN, stringName=Yimeng HAO, firstName=Yimeng, middleName=null, lastName=HAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
3.Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671309301035851, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309108097863, language=CN, stringName=郝依萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 3, address=1.中国医药工业研究总院,上海 201203
3.复旦大学,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671308659307319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=1., ext=[AuthorCompanyExt(id=1327671308663501624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671308671890233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1327671308801913661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=3., ext=[AuthorCompanyExt(id=1327671308810302270, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308801913661, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fudan University, Shanghai 201203), AuthorCompanyExt(id=1327671308814496575, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308801913661, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学,上海 201203)])]), Author(id=1327671309363950413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jingma2019@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327671309435253584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309363950413, language=EN, stringName=Jing MA, firstName=Jing, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671309506556753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309363950413, language=CN, stringName=马璟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院,上海 201203
2.上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671308659307319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=1., ext=[AuthorCompanyExt(id=1327671308663501624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671308671890233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1327671308738999098, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=2., ext=[AuthorCompanyExt(id=1327671308743193403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1327671308747387708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益诺思生物技术股份有限公司,上海 201203)])])], keywords=[Keyword(id=1327671309657551698, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, language=EN, orderNo=1, keyword=protein drug), Keyword(id=1327671309728854867, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, language=EN, orderNo=2, keyword=quantitative analysis), Keyword(id=1327671309804352340, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, language=EN, orderNo=3, keyword=LC-MS/MS), Keyword(id=1327671309879849813, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, language=CN, orderNo=1, keyword=蛋白质药物), Keyword(id=1327671309942764374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, language=CN, orderNo=2, keyword=定量分析), Keyword(id=1327671310009873239, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, language=CN, orderNo=3, keyword=LC-MS/MS)], refs=[Reference(id=1327671310156673880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=LEADER B, BACA Q J, GOLAN D E.Protein therapeutics: a summary and pharmacological classification [J].Nat Rev Drug Discovery, 2008, 7(1): 21-39., articleTitle=null, refAbstract=null), Reference(id=1327671310227977049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=WALSH G.Biopharmaceutical benchmarks 2018 [J].Nat Biotechnol, 2018, 36(12): 1136-1145., articleTitle=null, refAbstract=null), Reference(id=1327671310311863130, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=SINGH S, KUMAR N K, DWIWEDI P, et al.Monoclonal antibodies: a review [J].Curr Clin Pharmacol, 2018,13(2): 85-99., articleTitle=null, refAbstract=null), Reference(id=1327671310378971995, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=DE LA TORRE B G, ALBERICIO F.The pharmaceutical industry in 2021.An analysis of FDA drug approvals from the perspective of molecules [J].Molecules, 2022, 27(3):1075-1090., articleTitle=null, refAbstract=null), Reference(id=1327671310437692252, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=DAMEN C W N, DE GROOT E R, HEIJ M, et al.Development and validation of an enzyme-linked immunosorbent assay for the quantification of trastuzumab in human serum and plasma [J].Anal Biochem, 2009, 391(2):114-120., articleTitle=null, refAbstract=null), Reference(id=1327671310500606813, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=DAMEN C W N, SCHELLENS J H M, BEIJNEN J H.Bioanalytical methods for the quantification of therapeutic monoclonal antibodies and their application in clinical pharmacokinetic studies [J].Hum Antibodies, 2009, 18(3):47-73., articleTitle=null, refAbstract=null), Reference(id=1327671310605464414, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SAVOIE N, GAROFOLO F, AMSTERDAM P V, et al.2010 White paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance [J].Bioanalysis, 2010, 2(12): 1945-1960., articleTitle=null, refAbstract=null), Reference(id=1327671310693544799, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=CASTEELE N V, BUURMAN D J, STURKENBOOM M G, et al.Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays [J].Aliment Pharmacol Ther, 2012, 36(8): 765-771., articleTitle=null, refAbstract=null), Reference(id=1327671310777430880, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=HOOFNAGLE A N, WENER M H.The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry [J].J Immunol Methods, 2009, 347(1):3-11., articleTitle=null, refAbstract=null), Reference(id=1327671312488706913, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=CICCIMARO E, BLAIR L A.Stable-isotope dilution LC-MS for quantitative biomarker analysis [J].Bioanalysis,2010, 2(2): 311-341., articleTitle=null, refAbstract=null), Reference(id=1327671312572592994, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG S, JIAN W.Recent advances in absolute quantification of peptides and proteins using LC-MS [J].Rev Anal Chem, 2014, 33(1): 31-47., articleTitle=null, refAbstract=null), Reference(id=1327671312664867683, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=LI H, ORTIZ R, TRAN L, et al.General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies [J].Anal Chem,2012, 84(3): 1267-1273., articleTitle=null, refAbstract=null), Reference(id=1327671312731976548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=JIANG H, ZENG J, TITSCH C, et al.Fully validated LC-MS/MS assay for the simultaneous quantitation of co-administered therapeutic antibodies in cynomolgus monkey serum [J].Anal Chem, 2013, 85(20): 9859-9867., articleTitle=null, refAbstract=null), Reference(id=1327671312841028453, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=JIAN W, EDOM R W, WANG D, et al.Relative quantitation of glycoisoforms of intact apolipoprotein C3 in human plasma by liquid chromatography-high-resolution mass spectrometry [J].Anal Chem, 2013, 85(5): 2867-2874., articleTitle=null, refAbstract=null), Reference(id=1327671312924914534, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=KELLIE J F, KEHLER J R, MENCKEN T J, et al.A whole-molecule immunocapture LC-MS approach for the in vivo quantitation of biotherapeutics [J].Bioanalysis, 2016,8(20): 2103-2114., articleTitle=null, refAbstract=null), Reference(id=1327671313000412007, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=LANSHOEFT C, CIANFERANI S, HEUDI O.Generic hybrid ligand binding assay liquid chromatography high-resolution mass spectrometry-based workflow for multiplexed human Immunoglobulin G1 quantification at the intact protein level: application to preclinical pharmacokinetic studies [J].Anal Chem, 2017, 89(4): 2628-2635., articleTitle=null, refAbstract=null), Reference(id=1327671313071715176, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLEMAN T, JOURDIL J F, VEYRET E G, et al.A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: application for adalimumab therapeutic drug monitoring in patients with Crohn's disease [J].Anal Chim Acta, 2019, 1067: 63-70., articleTitle=null, refAbstract=null), Reference(id=1327671313143018345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG L, VASICEK L A, HSIEH S, et al.Top-down LC-MS quantitation of intact denatured and native monoclonal antibodies in biological samples [J].Bioanalysis, 2018,10(13): 1039-1054., articleTitle=null, refAbstract=null), Reference(id=1327671313205932906, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=MACLEAN B, TOMAZELA D M, SHULMAN N, et al.Skyline: an open source document editor for creating and analyzing targeted proteomics experiments [J].Bioinformatics, 2010, 26(7): 966-968., articleTitle=null, refAbstract=null), Reference(id=1327671313277236075, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=DEUTSCH E W, LAM H, AEBERSOLD R.PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows [J].EMBO Rep, 2008, 9(5): 429-434., articleTitle=null, refAbstract=null), Reference(id=1327671313348539244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE J W, KELLEY M, KING L E, et al.Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development [J].AAPS J, 2011, 13(1): 99-110., articleTitle=null, refAbstract=null), Reference(id=1327671313411453805, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=BRONSEMA K J, BISCHOFF R, MERBEL N C.Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry [J].J Chromatogr B, 2012, 893: 1-14., articleTitle=null, refAbstract=null), Reference(id=1327671313482756974, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=AMRANI M E, DONNERS A A M, HACK C E, et al.Six-step workflow for the quantification of therapeutic monoclonal antibodies in biological matrices with liquid chromatography mass spectrometry - a tutorial [J].Anal Chim Acta, 2019, 1080: 22-34., articleTitle=null, refAbstract=null), Reference(id=1327671313541477231, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=TODOROKI K, MIZUNO H, SUGIYAMA E, et al.Bioanalytical methods for therapeutic monoclonal antibodies and antibody-drug conjugates: a review of recent advances and future perspectives [J].J Pharm Biomed Anal, 2020,179: 112991., articleTitle=null, refAbstract=null), Reference(id=1327671313600197488, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIU H H, TSAI I L, LU Y S, et al.Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma [J].Anal Bioanal Chem, 2017, 409(28): 6583-6593., articleTitle=null, refAbstract=null), Reference(id=1327671313663112049, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=OSAKI F, TABATA K, OE T.Quantitative LC/ESI-SRM/MS of antibody biopharmaceuticals: use of a homologous antibody as an internal standard and three-step method development [J].Anal Bioanal Chem, 2017, 409(23):5523-5532., articleTitle=null, refAbstract=null), Reference(id=1327671313721832306, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=LEGERON R, XUEREB F, CHAIGNEPAIN S, et al.A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches [J].J Chromatogr B, 2017, 1070: 43-53., articleTitle=null, refAbstract=null), Reference(id=1327671313780552563, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=DUBOIS M, FENAILLE F, CLEMENT G, et al.Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum [J].Anal Chem, 2008, 80(5): 1737-1745., articleTitle=null, refAbstract=null), Reference(id=1327671313851855732, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG Y, WYSOCKI E, ANTWI K, et al.Development and validation of a targeted affinity-enrichment and LC-MS/MS proteomics approach for the therapeutic monitoring of adalimumab [J].Clin Chim Acta, 2018, 483: 308-314., articleTitle=null, refAbstract=null), Reference(id=1327671313918964597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIU H H, LIAO H W, SHAO Y Y, et al.Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS [J].Anal Chim Acta, 2018,1019: 93-102., articleTitle=null, refAbstract=null), Reference(id=1327671313981879158, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG Z, HAYES M, FANG X, et al.LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup [J].Anal Chem, 2007, 79(24): 9294-9301., articleTitle=null, refAbstract=null), Reference(id=1327671314048988023, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=HEUDI O, BARTEAU S, ZIMMER D, et al.Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry [J].Anal Chem, 2008, 80: 4200-4207., articleTitle=null, refAbstract=null), Reference(id=1327671314116096888, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=BRUN V, DUPUIS A, ADRAIT A, et al.Isotope-labeled protein standards: toward absolute quantitative proteomics[J].Mol Cell Proteomics, 2007, 6(12): 2139-2149., articleTitle=null, refAbstract=null), Reference(id=1327671314174817145, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=BRUN V, MASSELON C, GARIN J, et al.Isotope dilution strategies for absolute quantitative proteomics [J].J Proteomics, 2009, 72(5): 740-749., articleTitle=null, refAbstract=null), Reference(id=1327671314237731706, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=KUHN E, WHITEAKER J R, MANI D R, et al.Interlaboratory evaluation of automated, multiplexed peptide immune affinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma [J].Mol Cell Proteomics, 2012, 11(6): 111., articleTitle=null, refAbstract=null), Reference(id=1327671314334200699, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=BUDHRAJA R H, SHAH M A, SUTHAR M, et al.LC-MS/MS validation analysis of trastuzumab using dSIL approach for evaluating pharmacokinetics [J].Molecules, 2016,21(11): 1464-1474., articleTitle=null, refAbstract=null), Reference(id=1327671314409698172, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=NOURI-NIGJEH E, ZHANG M, JI T, et al.Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein [J].Anal Chem, 2014,86(7): 3575-3584., articleTitle=null, refAbstract=null), Reference(id=1327671314485195645, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=BARNIDGE D R, GOODMANSON M K, KLEE G G, et al.Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry [J].J Proteome Res, 2004, 3(3): 644-652., articleTitle=null, refAbstract=null), Reference(id=1327671314573276030, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=OCANA M F, JAMES I T, KABIR M, et al.Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS [J].Anal Chem, 2012, 84(14): 5959-5967., articleTitle=null, refAbstract=null), Reference(id=1327671314636190591, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=GONG C, ZHENG N, ZENG J, et al.Post-pellet-digestion precipitation and solid phase extraction: a practical and efficient workflow to extract surrogate peptides for ultra-high performance liquid chromatography-tandem mass spectrometry bioanalysis of a therapeutic antibody in the low ng/mL range [J].J Chromatogr A, 2015, 1424: 27-36., articleTitle=null, refAbstract=null), Reference(id=1327671314699105152, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=JI C, SADAGOPAN N, ZHANG Y, et al.A universal strategy for development of a method for absolute quantification of therapeutic monoclonal antibodies in biological matrices using differential dimethyl labeling coupled with ultra performance liquid chromatography-tandem mass spectrometry [J].Anal Chem, 2009, 81(22):9321-9328., articleTitle=null, refAbstract=null), Reference(id=1327671314757825409, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=NOVAKOVA L, VLCKOVA H.A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation [J].Anal Chim Acta, 2009, 656(1/2): 8-35., articleTitle=null, refAbstract=null), Reference(id=1327671314845905796, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=VAN DEN BROEK I, NIESSEN W M A, VAN DONGEN W D.Bioanalytical LC-MS/MS of protein-based biopharmaceuticals [J].J Chromatogr B, 2013, 929: 161-179., articleTitle=null, refAbstract=null), Reference(id=1327671314917208965, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=OUYANG Z, FURLONG M T, WU S, et al.Pellet digestion: a simple and efficient sample preparation technique for LC-MS/MS quantification of large therapeutic proteins in plasma [J].Bioanalysis, 2012, 4(1): 17-28., articleTitle=null, refAbstract=null), Reference(id=1327671314988512134, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=LANSHOEFT C, WOLF T, HEUDI O, et al.The use of generic surrogate peptides for the quantitative analysis of human immunoglobulin G1 in pre-clinical species with high-resolution mass spectrometry [J].Anal Bioanal Chem,2016, 408(6): 1687-1699., articleTitle=null, refAbstract=null), Reference(id=1327671315047232391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=AMRANI M E, SZANTO C L, HACK C E, et al.Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry [J].Anal Bioanal Chem, 2018, 410(23):5849-5858., articleTitle=null, refAbstract=null), Reference(id=1327671315122729864, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=YUAN L, ARNOLD M E, AUBRY A F, et al.Simple and efficient digestion of a monoclonal antibody in serum using pellet digestion: comparison with traditional digestion methods in LC-MS/MS bioanalysis [J].Bioanalysis, 2012,4(24): 2887-2896., articleTitle=null, refAbstract=null), Reference(id=1327671315185644425, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=ANDERSON N L, ANDERSON N G.The human plasma proteome: history, character, and diagnostic prospects [J].Mol Cell Proteomics, 2002, 1(11): 845-867., articleTitle=null, refAbstract=null), Reference(id=1327671315252753290, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=KATAOKA H.New trends in sample preparation for clinical and pharmaceutical analysis [J].TrAC-Trends Anal Chem,2003, 22(4): 232-244., articleTitle=null, refAbstract=null), Reference(id=1327671316863366028, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=YUAN L, AUBRY A F, ARNOLD M E, et al.Systematic investigation of orthogonal SPE sample preparation for the LC-MS/MS bioanalysis of a monoclonal antibody after pellet digestion [J].Bioanalysis, 2013, 5(19): 2379-2391., articleTitle=null, refAbstract=null), Reference(id=1327671316922086285, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=AMRANI M E, VAN DEN BROEK M P H, GOBEL C, et al.Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha-based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: a target-based, sensitive and cost-effective method [J].J Chromatogr A, 2016, 1454: 42-48., articleTitle=null, refAbstract=null), Reference(id=1327671316985000846, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=VIALARET J, BROUTIN S, PUGNIER C, et al.What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum? [J].Bioanalysis, 2018, 10(10): 723-735., articleTitle=null, refAbstract=null), Reference(id=1327671317043721103, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=DOMANSKI D, PERCY A J, YANG J, et al.MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma [J].Proteomics, 2012,12(8): 1222-1243., articleTitle=null, refAbstract=null), Reference(id=1327671317115024272, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=HANSEN K, SZARKA S, ESCOFFIER E, et al.Glu-C, an alternative digestive enzyme for the quantitative LC-MS/MS analysis of an IgG-based antibody biotherapeutic [J].Bioanalysis, 2018, 10(13): 997-1007., articleTitle=null, refAbstract=null), Reference(id=1327671317190521745, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=IWAMOTO N, SHIMADA T, UMINO Y, et al.Selective detection of complementarity-determining regions of monoclonal antibody by limiting protease access to the substrate: nano-surface and molecular-orientation limited proteolysis [J].Analyst, 2014, 139(3): 576-580., articleTitle=null, refAbstract=null), Reference(id=1327671317249242002, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=Food and Drug Administration.Bioanalytical method validation guidance for industry [S].The United States of America, 2018., articleTitle=null, refAbstract=null), Reference(id=1327671317303767955, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=European Medicines Agency.Guideline on bioanalytical method validation [S].Europe, 2011., articleTitle=null, refAbstract=null), Reference(id=1327671317362488212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=JENKINS R, DUGGAN J X, AUBRY A F, et al.Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeutics [J].AAPS J, 2015,17(1): 1-16., articleTitle=null, refAbstract=null), Reference(id=1327671317425402773, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=KONG L, LIU F, HUO L, et al.A novel LC-MS/MS approach to the pharmacokinetic study of free and bound aflibercept simultaneously [J].Anal Bioanal Chem, 2020,412(4): 1003-1010., articleTitle=null, refAbstract=null), Reference(id=1327671317488317334, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=XU L, ZHANG Z, XU S, et al.Simultaneous quantification of total antibody and antibody-conjugated drug for XMT-1522 in human plasma using immunocapture-liquid chromatography/mass spectrometry [J].J Pharm Biomed Anal, 2019, 174: 441-449., articleTitle=null, refAbstract=null), Reference(id=1327671317576397719, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIU H H, TSAI Y J, LO C, et al.Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion [J].Anal Chim Acta, 2022, 1193:339319., articleTitle=null, refAbstract=null), Reference(id=1327671317635117976, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG F, LI D, KUFER R, et al.Versatile LC-MS based workflow with robust 0.1 ppm sensitivity for identifying residual HCPs in biotherapeutic products [J].Anal Chem,2021, 94(2): 723-731., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1327671308659307319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=1., ext=[AuthorCompanyExt(id=1327671308663501624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671308671890233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1327671308738999098, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=2., ext=[AuthorCompanyExt(id=1327671308743193403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1327671308747387708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益诺思生物技术股份有限公司,上海 201203)]), AuthorCompany(id=1327671308801913661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=3., ext=[AuthorCompanyExt(id=1327671308810302270, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308801913661, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fudan University, Shanghai 201203), AuthorCompanyExt(id=1327671308814496575, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308801913661, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.12.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.12.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.12.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.12.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1670601600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
LC-MS/MS技术在蛋白质药物生物定量分析中的应用进展
宇家仪 1, 2 , 郝依萌 1, 3 , 马璟 1, 2, *
中国医药工业杂志 | 综述 2022,53(12): 1689-1698
收起
收藏切换
中国医药工业杂志 |综述 2022 , 53 (12) : 1689 -1698
LC-MS/MS技术在蛋白质药物生物定量分析中的应用进展
全屏
[Author(id=1327671308873216833, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671308961297220, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671308873216833, language=EN, stringName=Jiayi YU, firstName=Jiayi, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671309036794693, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671308873216833, language=CN, stringName=宇家仪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院,上海 201203
2.上海益诺思生物技术股份有限公司,上海 201203, bio={"content":"

宇家仪(1996—),女,硕士,从事抗体分析研究。

"}, bioImg=null, bioContent=

宇家仪(1996—),女,硕士,从事抗体分析研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671308659307319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=1., ext=[AuthorCompanyExt(id=1327671308663501624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671308671890233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1327671308738999098, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=2., ext=[AuthorCompanyExt(id=1327671308743193403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1327671308747387708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益诺思生物技术股份有限公司,上海 201203)])]), Author(id=1327671309108097863, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327671309217149770, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309108097863, language=EN, stringName=Yimeng HAO, firstName=Yimeng, middleName=null, lastName=HAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 3, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
3.Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671309301035851, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309108097863, language=CN, stringName=郝依萌, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 3, address=1.中国医药工业研究总院,上海 201203
3.复旦大学,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671308659307319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=1., ext=[AuthorCompanyExt(id=1327671308663501624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671308671890233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1327671308801913661, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=3., ext=[AuthorCompanyExt(id=1327671308810302270, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308801913661, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Fudan University, Shanghai 201203), AuthorCompanyExt(id=1327671308814496575, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308801913661, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学,上海 201203)])]), Author(id=1327671309363950413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jingma2019@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327671309435253584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309363950413, language=EN, stringName=Jing MA, firstName=Jing, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.China State Institute of Pharmaceutical Industry, Shanghai 201203
2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327671309506556753, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, authorId=1327671309363950413, language=CN, stringName=马璟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院,上海 201203
2.上海益诺思生物技术股份有限公司,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327671308659307319, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=1., ext=[AuthorCompanyExt(id=1327671308663501624, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1327671308671890233, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308659307319, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院,上海 201203)]), AuthorCompany(id=1327671308738999098, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, xref=2., ext=[AuthorCompanyExt(id=1327671308743193403, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203), AuthorCompanyExt(id=1327671308747387708, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671202388227062, companyId=1327671308738999098, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海益诺思生物技术股份有限公司,上海 201203)])])]
宇家仪1, 2, 郝依萌1, 3, 马璟1, 2, *
作者信息
  • 1.中国医药工业研究总院,上海 201203
  • 2.上海益诺思生物技术股份有限公司,上海 201203
  • 3.复旦大学,上海 201203
通讯作者:
马璟(1963—),女,研究员,博士生导师,从事药物毒理学/药理学的研究。E-mail:
作者简介:

宇家仪(1996—),女,硕士,从事抗体分析研究。

Advances in LC-MS/MS for Biological Quantitative Analysis of Protein Drugs
Jiayi YU1, 2, Yimeng HAO1, 3, Jing MA1, 2, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.Shanghai InnoStar Biotech Co., Ltd., Shanghai 201203
  • 3.Fudan University, Shanghai 201203
出版时间: 2022-12-10 doi: 10.16522/j.cnki.cjph.2022.12.003
文章导航
收藏切换

蛋白质药物包括治疗用蛋白质(酶和调节蛋白)、靶向蛋白质(抗体药物)、蛋白质疫苗及诊断用蛋白质等,因特异性强、不良反应小且疗效显著而成为新药研发的热点领域之一。随着蛋白质药物的快速发展,对其生物分析方法也提出了更高的要求。为支持此类药物在药代动力学和毒代动力学方面的研究,需建立更加灵敏、准确和高通量的生物分析方法。近年来,液相色谱-串联质谱(LC-MS/MS)技术发展迅速,已成为蛋白质药物定量分析的新方法。该研究介绍了LC-MS/MS技术在蛋白质药物定量分析方法中的应用进展,并详细介绍了自下而上分析方法的具体试验流程,为LC-MS/MS技术测定蛋白质药物的研究提供了参考。

蛋白质药物  /  定量分析  /  LC-MS/MS

Protein drugs include therapeutic proteins with enzymatic or regulatory activity, targeted protein such as antibody drugs, protein vaccines and protein diagnostics. Protein drugs have been one of the most focused areas in new drug development due to their strong specificity, slight adverse drug reaction and significant therapeutic effect. With the rapid development of protein drugs, higher requirements are put forward for their bioanalysis methods. To support the research of pharmacokinetics and toxicokinetics, more sensitive, accurate and high-throughput bioanalytical methods need to be established. In recent years, LC-MS/MS has emerged as a promising and versatile tool for quantitative analysis of protein drugs, owing to its rapid development. In this study, the application progress of LC-MS/MS to the quantitative analysis of protein drugs is summarized, and the specific experimental process of bottom-up analysis method in detail is introduced, which provides a reference for the study of LC-MS/MS in the determination of protein drugs.

protein drug  /  quantitative analysis  /  LC-MS/MS
宇家仪, 郝依萌, 马璟. LC-MS/MS技术在蛋白质药物生物定量分析中的应用进展. 中国医药工业杂志, 2022 , 53 (12) : 1689 -1698 . DOI: 10.16522/j.cnki.cjph.2022.12.003
Jiayi YU, Yimeng HAO, Jing MA. Advances in LC-MS/MS for Biological Quantitative Analysis of Protein Drugs[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (12) : 1689 -1698 . DOI: 10.16522/j.cnki.cjph.2022.12.003

参考文献 引证文献
排序方式:
[1]
LEADER B, BACA Q J, GOLAN D E.Protein therapeutics: a summary and pharmacological classification [J].Nat Rev Drug Discovery, 2008, 7(1): 21-39.
[2]
WALSH G.Biopharmaceutical benchmarks 2018 [J].Nat Biotechnol, 2018, 36(12): 1136-1145.
[3]
SINGH S, KUMAR N K, DWIWEDI P, et al.Monoclonal antibodies: a review [J].Curr Clin Pharmacol, 2018,13(2): 85-99.
[4]
DE LA TORRE B G, ALBERICIO F.The pharmaceutical industry in 2021.An analysis of FDA drug approvals from the perspective of molecules [J].Molecules, 2022, 27(3):1075-1090.
[5]
DAMEN C W N, DE GROOT E R, HEIJ M, et al.Development and validation of an enzyme-linked immunosorbent assay for the quantification of trastuzumab in human serum and plasma [J].Anal Biochem, 2009, 391(2):114-120.
[6]
DAMEN C W N, SCHELLENS J H M, BEIJNEN J H.Bioanalytical methods for the quantification of therapeutic monoclonal antibodies and their application in clinical pharmacokinetic studies [J].Hum Antibodies, 2009, 18(3):47-73.
[7]
SAVOIE N, GAROFOLO F, AMSTERDAM P V, et al.2010 White paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance [J].Bioanalysis, 2010, 2(12): 1945-1960.
[8]
CASTEELE N V, BUURMAN D J, STURKENBOOM M G, et al.Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays [J].Aliment Pharmacol Ther, 2012, 36(8): 765-771.
[9]
HOOFNAGLE A N, WENER M H.The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry [J].J Immunol Methods, 2009, 347(1):3-11.
[10]
CICCIMARO E, BLAIR L A.Stable-isotope dilution LC-MS for quantitative biomarker analysis [J].Bioanalysis,2010, 2(2): 311-341.
[11]
ZHANG S, JIAN W.Recent advances in absolute quantification of peptides and proteins using LC-MS [J].Rev Anal Chem, 2014, 33(1): 31-47.
[12]
LI H, ORTIZ R, TRAN L, et al.General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies [J].Anal Chem,2012, 84(3): 1267-1273.
[13]
JIANG H, ZENG J, TITSCH C, et al.Fully validated LC-MS/MS assay for the simultaneous quantitation of co-administered therapeutic antibodies in cynomolgus monkey serum [J].Anal Chem, 2013, 85(20): 9859-9867.
[14]
JIAN W, EDOM R W, WANG D, et al.Relative quantitation of glycoisoforms of intact apolipoprotein C3 in human plasma by liquid chromatography-high-resolution mass spectrometry [J].Anal Chem, 2013, 85(5): 2867-2874.
[15]
KELLIE J F, KEHLER J R, MENCKEN T J, et al.A whole-molecule immunocapture LC-MS approach for the in vivo quantitation of biotherapeutics [J].Bioanalysis, 2016,8(20): 2103-2114.
[16]
LANSHOEFT C, CIANFERANI S, HEUDI O.Generic hybrid ligand binding assay liquid chromatography high-resolution mass spectrometry-based workflow for multiplexed human Immunoglobulin G1 quantification at the intact protein level: application to preclinical pharmacokinetic studies [J].Anal Chem, 2017, 89(4): 2628-2635.
[17]
WILLEMAN T, JOURDIL J F, VEYRET E G, et al.A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: application for adalimumab therapeutic drug monitoring in patients with Crohn's disease [J].Anal Chim Acta, 2019, 1067: 63-70.
[18]
ZHANG L, VASICEK L A, HSIEH S, et al.Top-down LC-MS quantitation of intact denatured and native monoclonal antibodies in biological samples [J].Bioanalysis, 2018,10(13): 1039-1054.
[19]
MACLEAN B, TOMAZELA D M, SHULMAN N, et al.Skyline: an open source document editor for creating and analyzing targeted proteomics experiments [J].Bioinformatics, 2010, 26(7): 966-968.
[20]
DEUTSCH E W, LAM H, AEBERSOLD R.PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows [J].EMBO Rep, 2008, 9(5): 429-434.
[21]
LEE J W, KELLEY M, KING L E, et al.Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development [J].AAPS J, 2011, 13(1): 99-110.
[22]
BRONSEMA K J, BISCHOFF R, MERBEL N C.Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry [J].J Chromatogr B, 2012, 893: 1-14.
[23]
AMRANI M E, DONNERS A A M, HACK C E, et al.Six-step workflow for the quantification of therapeutic monoclonal antibodies in biological matrices with liquid chromatography mass spectrometry - a tutorial [J].Anal Chim Acta, 2019, 1080: 22-34.
[24]
TODOROKI K, MIZUNO H, SUGIYAMA E, et al.Bioanalytical methods for therapeutic monoclonal antibodies and antibody-drug conjugates: a review of recent advances and future perspectives [J].J Pharm Biomed Anal, 2020,179: 112991.
[25]
CHIU H H, TSAI I L, LU Y S, et al.Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma [J].Anal Bioanal Chem, 2017, 409(28): 6583-6593.
[26]
OSAKI F, TABATA K, OE T.Quantitative LC/ESI-SRM/MS of antibody biopharmaceuticals: use of a homologous antibody as an internal standard and three-step method development [J].Anal Bioanal Chem, 2017, 409(23):5523-5532.
[27]
LEGERON R, XUEREB F, CHAIGNEPAIN S, et al.A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches [J].J Chromatogr B, 2017, 1070: 43-53.
[28]
DUBOIS M, FENAILLE F, CLEMENT G, et al.Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum [J].Anal Chem, 2008, 80(5): 1737-1745.
[29]
YANG Y, WYSOCKI E, ANTWI K, et al.Development and validation of a targeted affinity-enrichment and LC-MS/MS proteomics approach for the therapeutic monitoring of adalimumab [J].Clin Chim Acta, 2018, 483: 308-314.
[30]
CHIU H H, LIAO H W, SHAO Y Y, et al.Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS [J].Anal Chim Acta, 2018,1019: 93-102.
[31]
YANG Z, HAYES M, FANG X, et al.LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup [J].Anal Chem, 2007, 79(24): 9294-9301.
[32]
HEUDI O, BARTEAU S, ZIMMER D, et al.Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry [J].Anal Chem, 2008, 80: 4200-4207.
[33]
BRUN V, DUPUIS A, ADRAIT A, et al.Isotope-labeled protein standards: toward absolute quantitative proteomics[J].Mol Cell Proteomics, 2007, 6(12): 2139-2149.
[34]
BRUN V, MASSELON C, GARIN J, et al.Isotope dilution strategies for absolute quantitative proteomics [J].J Proteomics, 2009, 72(5): 740-749.
[35]
KUHN E, WHITEAKER J R, MANI D R, et al.Interlaboratory evaluation of automated, multiplexed peptide immune affinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma [J].Mol Cell Proteomics, 2012, 11(6): 111.
[36]
BUDHRAJA R H, SHAH M A, SUTHAR M, et al.LC-MS/MS validation analysis of trastuzumab using dSIL approach for evaluating pharmacokinetics [J].Molecules, 2016,21(11): 1464-1474.
[37]
NOURI-NIGJEH E, ZHANG M, JI T, et al.Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein [J].Anal Chem, 2014,86(7): 3575-3584.
[38]
BARNIDGE D R, GOODMANSON M K, KLEE G G, et al.Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS/MS using protein cleavage and isotope dilution mass spectrometry [J].J Proteome Res, 2004, 3(3): 644-652.
[39]
OCANA M F, JAMES I T, KABIR M, et al.Clinical pharmacokinetic assessment of an anti-MAdCAM monoclonal antibody therapeutic by LC-MS/MS [J].Anal Chem, 2012, 84(14): 5959-5967.
[40]
GONG C, ZHENG N, ZENG J, et al.Post-pellet-digestion precipitation and solid phase extraction: a practical and efficient workflow to extract surrogate peptides for ultra-high performance liquid chromatography-tandem mass spectrometry bioanalysis of a therapeutic antibody in the low ng/mL range [J].J Chromatogr A, 2015, 1424: 27-36.
[41]
JI C, SADAGOPAN N, ZHANG Y, et al.A universal strategy for development of a method for absolute quantification of therapeutic monoclonal antibodies in biological matrices using differential dimethyl labeling coupled with ultra performance liquid chromatography-tandem mass spectrometry [J].Anal Chem, 2009, 81(22):9321-9328.
[42]
NOVAKOVA L, VLCKOVA H.A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation [J].Anal Chim Acta, 2009, 656(1/2): 8-35.
[43]
VAN DEN BROEK I, NIESSEN W M A, VAN DONGEN W D.Bioanalytical LC-MS/MS of protein-based biopharmaceuticals [J].J Chromatogr B, 2013, 929: 161-179.
[44]
OUYANG Z, FURLONG M T, WU S, et al.Pellet digestion: a simple and efficient sample preparation technique for LC-MS/MS quantification of large therapeutic proteins in plasma [J].Bioanalysis, 2012, 4(1): 17-28.
[45]
LANSHOEFT C, WOLF T, HEUDI O, et al.The use of generic surrogate peptides for the quantitative analysis of human immunoglobulin G1 in pre-clinical species with high-resolution mass spectrometry [J].Anal Bioanal Chem,2016, 408(6): 1687-1699.
[46]
AMRANI M E, SZANTO C L, HACK C E, et al.Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry [J].Anal Bioanal Chem, 2018, 410(23):5849-5858.
[47]
YUAN L, ARNOLD M E, AUBRY A F, et al.Simple and efficient digestion of a monoclonal antibody in serum using pellet digestion: comparison with traditional digestion methods in LC-MS/MS bioanalysis [J].Bioanalysis, 2012,4(24): 2887-2896.
[48]
ANDERSON N L, ANDERSON N G.The human plasma proteome: history, character, and diagnostic prospects [J].Mol Cell Proteomics, 2002, 1(11): 845-867.
[49]
KATAOKA H.New trends in sample preparation for clinical and pharmaceutical analysis [J].TrAC-Trends Anal Chem,2003, 22(4): 232-244.
[50]
YUAN L, AUBRY A F, ARNOLD M E, et al.Systematic investigation of orthogonal SPE sample preparation for the LC-MS/MS bioanalysis of a monoclonal antibody after pellet digestion [J].Bioanalysis, 2013, 5(19): 2379-2391.
[51]
AMRANI M E, VAN DEN BROEK M P H, GOBEL C, et al.Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha-based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: a target-based, sensitive and cost-effective method [J].J Chromatogr A, 2016, 1454: 42-48.
[52]
VIALARET J, BROUTIN S, PUGNIER C, et al.What sample preparation should be chosen for targeted MS monoclonal antibody quantification in human serum? [J].Bioanalysis, 2018, 10(10): 723-735.
[53]
DOMANSKI D, PERCY A J, YANG J, et al.MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma [J].Proteomics, 2012,12(8): 1222-1243.
[54]
HANSEN K, SZARKA S, ESCOFFIER E, et al.Glu-C, an alternative digestive enzyme for the quantitative LC-MS/MS analysis of an IgG-based antibody biotherapeutic [J].Bioanalysis, 2018, 10(13): 997-1007.
[55]
IWAMOTO N, SHIMADA T, UMINO Y, et al.Selective detection of complementarity-determining regions of monoclonal antibody by limiting protease access to the substrate: nano-surface and molecular-orientation limited proteolysis [J].Analyst, 2014, 139(3): 576-580.
[56]
Food and Drug Administration.Bioanalytical method validation guidance for industry [S].The United States of America, 2018.
[57]
European Medicines Agency.Guideline on bioanalytical method validation [S].Europe, 2011.
[58]
JENKINS R, DUGGAN J X, AUBRY A F, et al.Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeutics [J].AAPS J, 2015,17(1): 1-16.
[59]
KONG L, LIU F, HUO L, et al.A novel LC-MS/MS approach to the pharmacokinetic study of free and bound aflibercept simultaneously [J].Anal Bioanal Chem, 2020,412(4): 1003-1010.
[60]
XU L, ZHANG Z, XU S, et al.Simultaneous quantification of total antibody and antibody-conjugated drug for XMT-1522 in human plasma using immunocapture-liquid chromatography/mass spectrometry [J].J Pharm Biomed Anal, 2019, 174: 441-449.
[61]
CHIU H H, TSAI Y J, LO C, et al.Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion [J].Anal Chim Acta, 2022, 1193:339319.
[62]
YANG F, LI D, KUFER R, et al.Versatile LC-MS based workflow with robust 0.1 ppm sensitivity for identifying residual HCPs in biotherapeutic products [J].Anal Chem,2021, 94(2): 723-731.
2022年第53卷第12期
82
22
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.12.003
  • 接收时间:2022-03-01
  • 首发时间:2026-11-12
  • 出版时间:2022-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-03-01
基金
作者信息
    1.中国医药工业研究总院,上海 201203
    2.上海益诺思生物技术股份有限公司,上海 201203
    3.复旦大学,上海 201203

通讯作者:

马璟(1963—),女,研究员,博士生导师,从事药物毒理学/药理学的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.12.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏